111 related articles for article (PubMed ID: 7914378)
1. Expression of P-glycoprotein influences resistance against anthracyclines in clinical gastric carcinomas.
Orita H; Maehara Y; Anai H; Baba H; Kusumoto H; Korenaga D; Sugimachi K
Semin Surg Oncol; 1994; 10(2):135-9. PubMed ID: 7914378
[TBL] [Abstract][Full Text] [Related]
2. Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin.
Okuyama T; Maehara Y; Endo K; Baba H; Adachi Y; Kuwano M; Sugimachi K
Cancer; 1994 Aug; 74(4):1230-6. PubMed ID: 8055443
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of SDI test for predicting effect of postoperative chemotherapy for patients with gastric cancer.
Baba H; Takeuchi H; Inutsuka S; Yamamoto M; Endo K; Ohno S; Maehara Y; Sugimachi K
Semin Surg Oncol; 1994; 10(2):140-4. PubMed ID: 8052784
[TBL] [Abstract][Full Text] [Related]
4. Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil.
Maehara Y; Anai H; Kusumoto H; Kusumoto T; Sugimachi K
Dis Colon Rectum; 1988 Jan; 31(1):62-7. PubMed ID: 3130239
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.
Kanematsu T; Maehara Y; Kusumoto T; Sugimachi K
Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1511-3. PubMed ID: 2846313
[TBL] [Abstract][Full Text] [Related]
6. Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer.
Kusumoto H; Maehara Y; Yoshida M; Takahashi I; Anai H; Sugimachi K
Anticancer Drugs; 1992 Feb; 3(1):33-8. PubMed ID: 1623213
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor effects of chemotherapeutic drugs on fresh human gastric cancer cells and their relationships to expressions of P-glycoprotein and glutathione S transferase-pi].
Zhang J; Ji J; Ji YB; Yuan F; Liu BY; Zhu ZG; Lin YZ
Ai Zheng; 2005 Apr; 24(4):432-7. PubMed ID: 15820065
[TBL] [Abstract][Full Text] [Related]
8. The succinate dehydrogenase inhibition test for evaluating biopsy specimens and resected tumors of advanced gastric cancer.
Kimura H; Yonemura Y; Ohyama S; Tsugawa K; Kinoshita K; Ninomiya I; Kosaka T; Miwa K; Miyazaki I; Tanaka M
Surg Today; 1992; 22(6):508-11. PubMed ID: 1472790
[TBL] [Abstract][Full Text] [Related]
9. The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.
Geng M; Wang L; Chen X; Cao R; Li P
Diagn Pathol; 2013 Dec; 8():198. PubMed ID: 24326092
[TBL] [Abstract][Full Text] [Related]
10. [Multi-institutional feasibility study of SDI test for its application to the adjuvant chemotherapy of gastric cancer].
Yamauchi M; Kondo T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):432-9. PubMed ID: 8452380
[TBL] [Abstract][Full Text] [Related]
11. Tumor tissue is more sensitive to mitomycin C, carboquone, and aclacinomycin A than is adjacent normal tissue in vitro.
Maehara Y; Kusumoto H; Kusumoto T; Anai H; Sugimachi K
J Surg Oncol; 1989 Jan; 40(1):4-7. PubMed ID: 2909804
[TBL] [Abstract][Full Text] [Related]
12. Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
Maehara Y; Anai H; Kusumoto H; Sugimachi K
Eur J Surg Oncol; 1987 Jun; 13(3):203-6. PubMed ID: 3036603
[TBL] [Abstract][Full Text] [Related]
13. [The sensitivity of 1,000 human tumors to antitumor drugs using the succinate dehydrogenase inhibition (SDI) test].
Miyamoto K; Fukuchi K
Rinsho Byori; 1990 Nov; 38(11):1273-8. PubMed ID: 2273570
[TBL] [Abstract][Full Text] [Related]
14. Antitumor chemosensitivity differs between clinical sarcoma and adenocarcinoma tissues.
Takeuchi H; Baba H; Inutsuka S; Takahashi I; Kusumoto H; Maehara Y; Sugimachi K
Anticancer Res; 1994; 14(1A):169-71. PubMed ID: 8166444
[TBL] [Abstract][Full Text] [Related]
15. Antitumor spectra of anthracyclines against gastric cancer tissues obtained from surgical specimens with reference to P-glycoprotein expression.
Furukawa T; Kubota T; Murata H; Tanino H; Yuasa S; Morita K; Ueno J; Kozakai K; Yano T
J Surg Oncol; 1998 Nov; 69(3):173-7. PubMed ID: 9846505
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitivity differences between primary and metastatic lesions of clinical gastric cancer.
Kusumoto H; Maehara Y; Kusumoto T; Anai H; Akazawa K; Sugimachi K
Eur J Surg Oncol; 1988 Dec; 14(6):685-9. PubMed ID: 3192005
[TBL] [Abstract][Full Text] [Related]
17. [Accordance of the chemosensitivity between clinical specimens and their xenografts in nude mice by SDI test and the value of in vivo chemosensitivity test using nude mice].
Sakamoto Y; Fujita M; Goi M; Tsukamoto F; Sugimoto T; Okuyama Y; Rhi M; Kusuyama T; Fujita F
Gan To Kagaku Ryoho; 1993 Mar; 20(4):447-54. PubMed ID: 8452382
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
[TBL] [Abstract][Full Text] [Related]
19. Lung adenocarcinoma is more sensitive than gastric adenocarcinoma to anticancer drugs in vitro.
Kohnoe S; Moriguchi S; Emi Y; Sakaguchi Y; Maehara Y; Ishida T; Mitsudomi T; Sugimachi K
Eur J Surg Oncol; 1991 Feb; 17(1):47-50. PubMed ID: 1995357
[TBL] [Abstract][Full Text] [Related]
20. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma.
Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
Eur Urol; 1993; 24(1):156-60. PubMed ID: 8103456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
